eslicarbazepine acetate has been researched along with Bilateral Headache in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 5 (83.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Agredano, PM; Bayarri, PG; Bermejo, PE; Campos, D; Falip, M; García-Morales, I; Gil-Nagel, A; Giráldez, BG; Gomariz, EL; González, FJL; Jiménez-Huete, A; Jovel, CE; Navacerrada, FJ; Ojeda, J; Palao, S; Pascual, MRQ; Prior, MJAA; Sáez, AA; Toledano, R | 1 |
Ben-Menachem, E; Elger, C; Keller, B; Kowacs, PA; Löffler, K; Rocha, JF; Soares-da-Silva, P; Trinka, E | 1 |
Blum, D; Fiedler-Kelly, J; Grinnell, T; Ludwig, EA; Passarell, JA; Sunkaraneni, S | 1 |
Holtkamp, M; Kockelmann, E; Lendemans, D; Losch, FP; McMurray, R | 1 |
Almeida, L; Gil-Nagel, A; Lopes-Lima, J; Maia, J; Soares-da-Silva, P | 1 |
Almeida, L; Ben-Menachem, E; Gabbai, AA; Hufnagel, A; Maia, J; Soares-da-Silva, P | 1 |
5 trial(s) available for eslicarbazepine acetate and Bilateral Headache
Article | Year |
---|---|
Efficacy and safety of eslicarbazepine acetate versus controlled-release carbamazepine monotherapy in newly diagnosed epilepsy: A phase III double-blind, randomized, parallel-group, multicenter study.
Topics: Adult; Alanine Transaminase; Anticonvulsants; Carbamazepine; Delayed-Action Preparations; Dibenzazepines; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Epilepsies, Partial; Equivalence Trials as Topic; Fatigue; Female; gamma-Glutamyltransferase; Headache; Humans; Logistic Models; Male; Middle Aged; Nausea; Treatment Outcome; Voltage-Gated Sodium Channel Blockers; Young Adult | 2018 |
Population Pharmacokinetics and Exposure-Response Analyses of Eslicarbazepine Acetate Efficacy and Safety in Monotherapy of Partial-Onset Seizures.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anticonvulsants; Dibenzazepines; Dizziness; Dose-Response Relationship, Drug; Drug-Related Side Effects and Adverse Reactions; Female; Headache; Healthy Volunteers; Humans; Hyponatremia; Male; Middle Aged; Models, Biological; Nausea; Seizures; Sodium; Treatment Outcome | 2018 |
[Anticonvulsant add-on therapy with Eslicarbazepine acetate : Results of the EPOS-study in adults in Germany].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Causality; Chemotherapy, Adjuvant; Comorbidity; Dibenzazepines; Dizziness; Dose-Response Relationship, Drug; Epilepsy; Fatigue; Female; Germany; Headache; Humans; Male; Middle Aged; Prevalence; Quality of Life; Risk Factors; Treatment Outcome; Voltage-Gated Sodium Channel Blockers; Young Adult | 2016 |
Efficacy and safety of 800 and 1200 mg eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Anticonvulsants; Dibenzazepines; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Epilepsies, Partial; Female; Headache; Humans; Male; Middle Aged; Nausea; Patient Selection; Placebos; Seizures; Treatment Outcome | 2009 |
Eslicarbazepine acetate as adjunctive therapy in adult patients with partial epilepsy.
Topics: Adult; Anticonvulsants; Dibenzazepines; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Synergism; Epilepsies, Partial; Female; Headache; Humans; Male; Middle Aged; Nausea; Seizures; Treatment Outcome | 2010 |
1 other study(ies) available for eslicarbazepine acetate and Bilateral Headache
Article | Year |
---|---|
Efficacy and safety of eslicarbazepine acetate monotherapy for partial-onset seizures: Experience from a multicenter, observational study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Child; Depression; Dibenzazepines; Dizziness; Female; Headache; Humans; Male; Middle Aged; Prospective Studies; Seizures; Spain; Treatment Outcome; Young Adult | 2017 |